Article ID Journal Published Year Pages File Type
5913414 Blood Cells, Molecules, and Diseases 2016 28 Pages PDF
Abstract
We conclude that the addition of CD135 and CD117 to the diagnosis can predict molecular aberrations in T-ALL settings, mainly segregating patients with FLT3-ITD, who would benefit from treatment with inhibitors of tyrosine.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Molecular Biology
Authors
, , , , , ,